Literature DB >> 24744384

Aerobic exercise training reduces arterial stiffness in metabolic syndrome.

David A Donley1, Sara B Fournier2, Brian L Reger1, Evan DeVallance2, Daniel E Bonner1, I Mark Olfert2, Jefferson C Frisbee3, Paul D Chantler4.   

Abstract

The metabolic syndrome (MetS) is associated with a threefold increase risk of cardiovascular disease (CVD) mortality partly due to increased arterial stiffening. We compared the effects of aerobic exercise training on arterial stiffening/mechanics in MetS subjects without overt CVD or type 2 diabetes. MetS and healthy control (Con) subjects underwent 8 wk of exercise training (ExT; 11 MetS and 11 Con) or remained inactive (11 MetS and 10 Con). The following measures were performed pre- and postintervention: radial pulse wave analysis (applanation tonometry) was used to measure augmentation pressure and index, central pressures, and an estimate of myocardial efficiency; arterial stiffness was assessed from carotid-femoral pulse-wave velocity (cfPWV, applanation tonometry); carotid thickness was assessed from B-mode ultrasound; and peak aerobic capacity (gas exchange) was performed in the seated position. Plasma matrix metalloproteinases (MMP) and CVD risk (Framingham risk score) were also assessed. cfPWV was reduced (P < 0.05) in MetS-ExT subjects (7.9 ± 0.6 to 7.2 ± 0.4 m/s) and Con-ExT (6.6 ± 1.8 to 5.6 ± 1.6 m/s). Exercise training reduced (P < 0.05) central systolic pressure (116 ± 5 to 110 ± 4 mmHg), augmentation pressure (9 ± 1 to 7 ± 1 mmHg), augmentation index (19 ± 3 to 15 ± 4%), and improved myocardial efficiency (155 ± 8 to 168 ± 9), but only in the MetS group. Aerobic capacity increased (P < 0.05) in MetS-ExT (16.6 ± 1.0 to 19.9 ± 1.0) and Con-ExT subjects (23.8 ± 1.6 to 26.3 ± 1.6). MMP-1 and -7 were correlated with cfPWV, and both MMP-1 and -7 were reduced post-ExT in MetS subjects. These findings suggest that some of the pathophysiological changes associated with MetS can be improved after aerobic exercise training, thereby lowering their cardiovascular risk.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  arterial stiffness; exercise training; metabolic syndrome

Mesh:

Year:  2014        PMID: 24744384      PMCID: PMC4044399          DOI: 10.1152/japplphysiol.00151.2014

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  42 in total

1.  Aging, habitual exercise, and dynamic arterial compliance.

Authors:  H Tanaka; F A Dinenno; K D Monahan; C M Clevenger; C A DeSouza; D R Seals
Journal:  Circulation       Date:  2000-09-12       Impact factor: 29.690

Review 2.  A comprehensive definition for metabolic syndrome.

Authors:  Paul L Huang
Journal:  Dis Model Mech       Date:  2009 May-Jun       Impact factor: 5.758

3.  Effects of aging on changing arterial compliance and left ventricular load in a northern Chinese urban community.

Authors:  A P Avolio; S G Chen; R P Wang; C L Zhang; M F Li; M F O'Rourke
Journal:  Circulation       Date:  1983-07       Impact factor: 29.690

4.  Experimental subendocardial ischemia in dogs with normal coronary arteries.

Authors:  G D Buckberg; D E Fixler; J P Archie; J I Hoffman
Journal:  Circ Res       Date:  1972-01       Impact factor: 17.367

5.  Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.

Authors:  Shaista Malik; Nathan D Wong; Stanley S Franklin; Tripthi V Kamath; Gilbert J L'Italien; Jose R Pio; G Rhys Williams
Journal:  Circulation       Date:  2004-08-23       Impact factor: 29.690

6.  General cardiovascular risk profile for use in primary care: the Framingham Heart Study.

Authors:  Ralph B D'Agostino; Ramachandran S Vasan; Michael J Pencina; Philip A Wolf; Mark Cobain; Joseph M Massaro; William B Kannel
Journal:  Circulation       Date:  2008-01-22       Impact factor: 29.690

7.  Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study.

Authors:  Arnt Erik Tjønna; Sang Jun Lee; Øivind Rognmo; Tomas O Stølen; Anja Bye; Per Magnus Haram; Jan Pål Loennechen; Qusai Y Al-Share; Eirik Skogvoll; Stig A Slørdahl; Ole J Kemi; Sonia M Najjar; Ulrik Wisløff
Journal:  Circulation       Date:  2008-07-07       Impact factor: 29.690

8.  Exercise reveals impairments in left ventricular systolic function in patients with metabolic syndrome.

Authors:  Sara B Fournier; Brian L Reger; David A Donley; Daniel E Bonner; Bradford E Warden; Wissam Gharib; Conard F Failinger; Melissa D Olfert; Jefferson C Frisbee; I Mark Olfert; Paul D Chantler
Journal:  Exp Physiol       Date:  2013-09-13       Impact factor: 2.969

9.  Central or peripheral systolic or pulse pressure: which best relates to target organs and future mortality?

Authors:  Kang-Ling Wang; Hao-Min Cheng; Shao-Yuan Chuang; Harold A Spurgeon; Chih-Tai Ting; Edward G Lakatta; Frank C P Yin; Pesus Chou; Chen-Huan Chen
Journal:  J Hypertens       Date:  2009-03       Impact factor: 4.844

10.  Aerobic training-induced improvements in arterial stiffness are not sustained in older adults with multiple cardiovascular risk factors.

Authors:  K M Madden; C Lockhart; D Cuff; T F Potter; G S Meneilly
Journal:  J Hum Hypertens       Date:  2012-09-06       Impact factor: 3.012

View more
  39 in total

1.  Effects on carotid-femoral pulse wave velocity 24 h post exercise in young healthy adults.

Authors:  Sophy J Perdomo; Anne M Moody; Stephanie M McCoy; Emma Barinas-Mitchell; John M Jakicic; Bethany Barone Gibbs
Journal:  Hypertens Res       Date:  2016-01-14       Impact factor: 3.872

Review 2.  Strategies for Achieving Healthy Vascular Aging.

Authors:  Kristen L Nowak; Matthew J Rossman; Michel Chonchol; Douglas R Seals
Journal:  Hypertension       Date:  2018-01-08       Impact factor: 10.190

3.  Is obesity predictive of cardiovascular dysfunction independent of cardiovascular risk factors?

Authors:  E DeVallance; S B Fournier; D A Donley; D E Bonner; K Lee; J C Frisbee; P D Chantler
Journal:  Int J Obes (Lond)       Date:  2014-06-24       Impact factor: 5.095

Review 4.  Arterial Ventricular Uncoupling With Age and Disease and Recoupling With Exercise.

Authors:  Paul D Chantler
Journal:  Exerc Sport Sci Rev       Date:  2017-04       Impact factor: 6.230

5.  Distinct temporal phases of microvascular rarefaction in skeletal muscle of obese Zucker rats.

Authors:  Jefferson C Frisbee; Adam G Goodwill; Stephanie J Frisbee; Joshua T Butcher; Robert W Brock; I Mark Olfert; Evan R DeVallance; Paul D Chantler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-10-10       Impact factor: 4.733

6.  Ambulatory blood pressure response to a bout of HIIT in metabolic syndrome patients.

Authors:  M Ramirez-Jimenez; F Morales-Palomo; J G Pallares; Ricardo Mora-Rodriguez; J F Ortega
Journal:  Eur J Appl Physiol       Date:  2017-05-10       Impact factor: 3.078

Review 7.  Aortic Stiffness in Aging and Hypertension: Prevention and Treatment with Habitual Aerobic Exercise.

Authors:  Gary L Pierce
Journal:  Curr Hypertens Rep       Date:  2017-10-18       Impact factor: 5.369

8.  Plasma matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs and aging and lifelong exercise adaptations in ventricular and arterial stiffness.

Authors:  Graeme Carrick-Ranson; Francis G Spinale; Paul S Bhella; Satyam Sarma; Shigeki Shibata; Naoki Fujimoto; Jeffrey L Hastings; Benjamin D Levine
Journal:  Exp Gerontol       Date:  2019-05-13       Impact factor: 4.032

9.  The effects of resistance exercise training on arterial stiffness in metabolic syndrome.

Authors:  E DeVallance; S Fournier; K Lemaster; C Moore; S Asano; D Bonner; D Donley; I M Olfert; P D Chantler
Journal:  Eur J Appl Physiol       Date:  2016-03-03       Impact factor: 3.078

10.  Vascular improvements in individuals with type 2 diabetes following a 1 year randomised controlled exercise intervention, irrespective of changes in cardiorespiratory fitness.

Authors:  Megan Hetherington-Rauth; João P Magalhães; Pedro B Júdice; Xavier Melo; Luís B Sardinha
Journal:  Diabetologia       Date:  2020-01-20       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.